Bee, Scorpion and Snake Venom may hold Cancer Cure

This is very interesting in that we are even able to target cancer stem cells and thus cut of   the spread of the cancer as well.  This is a much enhanced toxin protocol which may allow precise engineering.

There are many other effective protocols been developed but this one piggybacks the present protocols and may be easier to implement.  That matters when training is added into the cost of a roll out.

I see systems such as the Beck machine which while promising still demands skilled technicians  overseeing extended treatment  cycles which is not so easy to establish and initially support..

  
 

Bee, scorpion and snake venom may hold cancer cure

By Jen Christensen, CNN

updated 9:26 AM EDT, Tue August 12, 2014

http://www.cnn.com/2014/08/12/health/venom-nanotechnology-cancer/

It's ancient medicine with a sci-fi-sounding twist.

A scientist at the University of Illinois, Dipanjan Pan, and his team say they may have found a way to stop cancer cell growth, according to a paper presented at the American Chemical Society conference this week.

The work is in very early stages, but has shown success in stopping breast cancer and melanoma cell growth in lab tests. Pan's technique uses nanotechnology to deliver a synthesized element similar to the venom found in bees, snakes and scorpions.

Ancient texts show doctors have used venom to treat aliments for years. In 14 BC, the Greek writer Pliny the Elder described the use of bee venom as a cure for baldness. Doctors used beestings to treat the Emperor Charlemagne's gout in the 700s. Traditional Chinese medicine has used frog venom to fight liver, lung, colon and pancreatic cancers. Alternative doctors in Cuba have used scorpion venom to fight brain tumors.

The general problem with injecting someone with venom is that there can be harmful side effects. Beestings, for example, hurt and become inflamed because melittin, the main toxin in a bee's venom, destroys cell membranes. It can also cause blood to clot, damage the heart muscle and hurt healthy nerve cells.

The properties in venom that destroy cancer cells can have the same effect on healthy cells -- much in the same way chemotherapy causes cell damage, and painful side effects, while treating cancer.

But Pan's lab has developed a technique to separate out the important proteins and peptides in the venom so they can be used to stop cancer cell growth. His lab has found a way to synthesize these helpful cells.

"Since it's synthetic, there's no ambiguity" in what the substance contains, Pan said.

The synthetic material is then delivered to cancer cells using nanotechnology. In "camouflaging the whole toxin as a part of the nanoparticle," Pan said, it bypasses healthy cells and is attracted to only the cancer cells. In other words, it's so tightly packed into the nanoparticle it doesn't leak out and cause other problems.

Attached to the cancer cells, these nanoparticles with the synthesized venom can either slow down or stop cancer cell growth, and may ultimately stop the cancer from spreading.

Particles in bee venom seem to specifically stop the cancer stem cells.

"That's what we are interested in -- those are the cells responsible for metastasizing and also responsible for having the cancer cells grow back," Pan said. "If we can target better using this technique, we potentially have a better cancer treatment."

Unlike chemotherapy, this more targeted technique would, in theory, only affect cancer cells. If it's successful, this natural agent found in venom could become the basis for a whole legion of cancer-fighting drugs.

Pan's research builds on a growing body of scientific research that has shown toxins in venom can fight cancer cells without harming healthy cells. For example, Dr. Samuel Wickline at Washington University in St. Louis helped develop "nanobees" that are also being tested to see if they can deliver a synthesized version of the toxin found in bee venom to cancer cells in prostate cancer.

Next Pan's lab will try the synthesized venom and nanotechnology combination on cancer cells in rats and pigs. If successful, they'll then try the technique on humans. He predicts that step could happen in the next three to five years.